Document

30-day Notice (OMB#1110-0052)

ICR 202611-1110-004 · OMB 1110-0052 · Object 175128200.

Document Viewer [pdf]

Status: Original and derived artifacts are available for this document.

Download: pdf

Primary: pdfSource: application/pdf
Loading document viewer…

Document Metadata

Record metadata
application/pdf
30-day Notice (OMB#1110-0052)
govinfo, U. S. Government Publishing Office
2026-10-07
2026-10-07
complete

Extracted Text

64178

Federal Register / Vol. 91, No. 193 / Wednesday, October 7, 2026 / Notices

Holdings. RFAAX 1, at 4. That location
has been operating, and continues to
operate, as a marijuana cultivation
facility, growing both medical and
recreational marijuana, which is sold to
third-party marijuana dispensaries
operating within Colorado’s marijuana
market. RFAAX 1, at 4.
IV. Discussion

lotter on DSK8BHNXB4PROD with NOTICES1

Here, Applicant’s parent company,
MedPharm Holdings, and its sister
company, MX, have been manufacturing
marijuana without DEA registration for
at least the past 10 years. RFAAX 1, at
4. Further, Applicant’s parent company
and sister company have been engaged
in the manufacture of marijuana for sale
in the recreational market. RFAAX 1, at
4. Manufacturing marijuana without a
registration from DEA violates the CSA
and DEA regulations. 21 U.S.C.
822(a)(1), 823(a), 841(a)(1); 21 CFR
1301.11(a); Raich, 545 U.S. at 12–13.
Further, manufacturing marijuana for
the recreational market violates the CSA
and DEA regulations, and it constitutes
diversion of a Schedule I controlled
substance. 21 CFR 1301.13(k)(1)(iv),
1301.71(a), .72–.76, 1318.04(a); Raich,
545 U.S. at 12–13.
In sum, Applicant’s corporate
structure, acting through the company
that owns and controls Applicant and
its sister company, all of which are
managed by the same CEO, Mr. A.G.,6
has engaged in the unregistered
manufacture of marijuana for at least a
decade and has diverted marijuana into
the recreational market, in violation of
federal law. See Sections III–IV. The
unregistered manufacture of marijuana
and the diversion of marijuana into
recreational channels weigh against a
finding of registration being consistent
with the public interest and
demonstrate a lack of ‘‘prior compliance
with the’’ CSA and DEA regulations,
which also weigh against a finding of
registration being consistent with the
public interest. 21 U.S.C. 823(a)(6); 21
CFR 1318.05(b)(1).
Considering the unrebutted and
substantial evidence of record
establishing Applicant’s unregistered
manufacture of and diversion of a
Schedule I controlled substance, the
Agency determines that issuing
Applicant a manufacturer registration
(bulk) for marijuana would not be
6 See Pharmboy Ventures Unlimited, Inc., 77 FR
33770, 33771 n.2 (2012) (noting that ‘‘DEA has long
held that’’ the Agency ‘‘can look behind [an
entity’s] ownership structure’’ to evaluate the
conduct of the people making decisions regarding
the controlled substance side of the business)
(citing Carriage Apothecary, 52 FR 27599, 27599
(1987)).

VerDate Sep<11>2014

16:52 Oct 06, 2026

Jkt 271001

consistent with the public interest.7 21
U.S.C. 823(a)(6); 21 CFR 1318.05(b)(1).
Accordingly, the Agency will order the
denial of Applicant’s application for
registration.8

the legal effect of this document upon
publication in the Federal Register.

Order

[FR Doc. 2026–20553 Filed 10–6–26; 8:45 am]

Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
823(a), I hereby deny the pending
application for a DEA Certificate of
Registration, Control No. W16089931E,
submitted by MedPharm Research, LLC,
as well as any other pending application
of MedPharm Research, LLC, to amend
or modify this application, or for
additional registration in Colorado. This
Order is effective November 6, 2026.

This document of the Drug
Enforcement Administration was signed
on October 2, 2026, by DEA
Administrator Terrance C. Cole. That
document with the original signature
and date is maintained by DEA. For
administrative purposes only, and in
compliance with requirements of the
Office of the Federal Register, the
undersigned DEA Federal Register
Liaison Officer has been authorized to
sign and submit the document in
electronic format for publication, as an
official document of DEA. This
administrative process in no way alters
7 The burden is on the applicant to establish that

its registration is consistent with the public interest.
21 CFR 1301.44(a); 21 CFR 1318.03(b); RFAAX 1,
at 2. Here, by virtue of its default, Applicant has
failed to present any evidence whatsoever to
establish its registration is consistent with the
public interest, and the deemed admitted facts (i.e.,
noncompliance with the CSA, violation of the
registration requirement, and diversion of a
Schedule I controlled substance), weigh against a
finding in favor of registration. Although these are
only factors, they are dispositive here because
Applicant’s default means it not only waived the
right to present evidence regarding these factors,
but it also waived the right to present any other
evidence that its registration would be consistent
with the public interest.
8 Denial of Applicant’s application in this Order
does not prohibit Applicant from submitting an
application through the new framework established
for issuing registrations based on state licenses to
handle marijuana for medical purposes, if
applicable. See Schedules of Controlled Substances:
Rescheduling of Food and Drug Administration
Approved Products Containing Marijuana From
Schedule I to Schedule III; Corresponding Change
to Permit Requirements, 91 FR 22714, 22721 (2026)
(adding paragraph (k) to 21 CFR 1301.13
‘‘establish[ing] an expedited review process for
entities holding state medical marijuana licenses
who seek registration as a marijuana
manufacturer’’); see also id. at 22722 (adding
paragraphs (g)(2)–(4) to 21 CFR 1308.13 placing into
Schedule III marijuana, marijuana extract, and
delta-9-tetrahydrocannabinols ‘‘subject to a state
medical marijuana license’’).

Frm 00043

Fmt 4703

BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE
[OMB Number 1110–0052]

Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Title—Identity
History Summary Request Form (1–
783)
AGENCY: Criminal Justice Information

Signing Authority

PO 00000

Heather Achbach,
Federal Register Liaison Officer, Drug
Enforcement Administration.

Sfmt 4703

Services (CJIS) Division, Federal Bureau
of Investigation (FBI), Department of
Justice (DOJ).
ACTION: 30-Day notice.
SUMMARY: The CJIS, FBI, DOJ will be

submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection
was previously published in the Federal
Register on August 5, 2026, 91 FR
50558, allowing a 60-day comment
period.
DATES: Comments are encouraged and

will be accepted for 30 days until
November 5, 2026.
FOR FURTHER INFORMATION CONTACT: If

you have comments especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact: Brian A. Cain, 1000 Custer
Hollow Road, Clarksburg, WV 26306,
304–625–CJIS, [email protected].
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;

E:\FR\FM\07OCN1.SGM

07OCN1

Federal Register / Vol. 91, No. 193 / Wednesday, October 7, 2026 / Notices

lotter on DSK8BHNXB4PROD with NOTICES1

—Enhance the quality, utility, and
clarity of the information to be
collected; and/or
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Written comments and
recommendations for this information
collection should be submitted within
30 days of the publication of this notice
on the following website
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function and entering either the title of
the information collection or the OMB
Control Number 1110–0070. This
information collection request may be
viewed at www.reginfo.gov. Follow the
instructions to view Department of
Justice, information collections
currently under review by OMB. If you
submit a comment, please send a copy
to Brian Cain to [email protected].
DOJ seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOJ notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Abstract: Individuals interested in
obtaining a copy of their identification
record contained in the FBI’s Next
Generation Identification System. The
U.S. Department of Justice Order 556–
773 directs the FBI to publish rules for
the dissemination of arrest and
conviction records to the subjects of
such records upon request. This order
resulted in a determination that 28
United States Code 534 does not
prohibit the subjects of arrest and
convictions records from having access
to those records.
Overview of This Information
Collection
1. Type of Information Collection:
Revision of a currently approved
collection Title of the Form/Collection:
Identity History Summary Request Form
(1–783).
2. Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: 1110–0052, Form Identity
History Summary Request (1–783); CJIS
Division, FBI, DOJ.

VerDate Sep<11>2014

16:52 Oct 06, 2026

Jkt 271001

3. Affected public who will be asked
or required to respond, as well as a brief
abstract: Affected Public: Individuals;
Individuals wishing to obtain a copy of
their identification record based on US
DOJ Order 556–773.
4. Obligation to Respond: Required to
obtain or retain a benefit.
5. Total Estimated Number of
Respondents: 74,438 per year.
6. Estimated Time per Respondent: 5
minutes.
7. Frequency: Varies.
8. Total Estimated Annual Time
Burden: 6,203 hours.
9. Total Estimated Annual Other
Costs Burden: $27.72 avg hourly wage ×
6,203 hours = $171,947.00 cost burden.
If additional information is required,
contact: Darwin Arceo, Department
Clearance Officer, Enterprise Portfolio
Management, Justice Management
Division, United States Department of
Justice, Two Constitution Square, 145 N
Street NE, 4W–218 Washington, DC
20530.
Dated: October 5, 2026.
Darwin Arceo,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2026–20534 Filed 10–6–26; 8:45 am]
BILLING CODE 4410–02–P

DEPARTMENT OF JUSTICE
[CPCLO Order No. 010–2026]

Privacy Act of 1974; System of
Records
AGENCY: Drug Enforcement

Administration, United States
Department of Justice.
ACTION: Notice of a modified system of
records.
SUMMARY: Pursuant to the Privacy Act of

1974, and Office of Management and
Budget (OMB) Circular No. A–108,
notice is hereby given that the Drug
Enforcement Administration (DEA), a
component of the United States
Department of Justice (Department or
DOJ), proposes to modify and republish
a system of records notice titled
‘‘JUSTICE/DEA–021, DEA Aviation Unit
Reporting System,’’ 65 FR 24986, to be
retitled ‘‘DEA Aviation Division
Reporting System’’, which is the
repository of reporting records held by
DEA’s Aviation Division. DEA proposes
to update the categories of individuals
covered by the system, as well as record
categories, purpose of the system,
routine uses of records maintained in
the system and policies and practices
for storing, retrieving, retaining, and
disposing of records in the system.

PO 00000

Frm 00044

Fmt 4703

Sfmt 4703

64179

DATES: In accordance with 5 U.S.C.

552a(e)(4) and (11), this notice is
effective upon publication, subject to a
30-day period in which the public may
comment on the routine uses described
below. Therefore, please submit any
comments by November 5, 2026.
ADDRESSES: The public, Office of
Management and Budget, and Congress
are invited to submit any comments
online via the Federal e-Rulemaking
Portal: http://www.regulations.gov and
following the instructions for submitting
comments; by mail to the United States
Department of Justice, ATTN: Privacy
Analyst, Office of Privacy and Civil
Liberties, Two Constitution Square
(2CON), 145 N Street NE, Suite 8W.300,
Washington, DC 20530, by facsimile at
202–307–0693, or by email at
[email protected]. To
ensure proper handling, please
reference the above CPCLO Order No.
on your correspondence.
FOR FURTHER INFORMATION CONTACT:
David Makoto Hudson, Attorney, Drug
Enforcement Administration, Office of
Chief Counsel, Strategic Programs
Section, 8701 Morrissette Drive,
Springfield, VA 22152.
SUPPLEMENTARY INFORMATION: DEA is
proposing to modify this system to
update the categories of individuals
covered by the system. More
specifically, the modification will
reflect that the categories of individuals
covered by the system include DEA
employees and contractors and not just
DEA pilots, as well as vendors,
detainees, inmates, non-DEA law
enforcement personnel, and other
federal government employees and
contractors. Additional changes are
being made to this Notice to provide
greater clarity about the information
contained in the Inspection Division
Records and the types of information
that can be retrieved. The DEA also
proposes to update, add to, and/or
clarify the system location, the
categories of individuals covered by the
system; the record categories in the
system; the record source categories; the
purpose of the system; the system’s
routine uses; policies and practices for
storing, retrieving, retaining, and
disposing of records in the system; the
record access procedures; and
procedures to contest the accuracy of
records in the system. The purpose of
this modification is to update the
language to better reflect the
modernization of applications in DEA’s
information system related to controlled
substance transaction reporting and to
more accurately describe the breadth of
the records contained therein. Finally,
the modification will bring the SORN

E:\FR\FM\07OCN1.SGM

07OCN1